`
`Bausch Lomb Inc FDA Filings
`
`Bausch Lomb Inc
`
`FDA Filings
`This page includes the latest FDA filings for Bausch Lomb Inc. Currently, you
`will find the latest 100 filings for Premarket Notifications, Premarket
`Applications, De Novo Applications, and GUDID registrations.
`
`FDA Registration(s)
`
`Registration Number
`
`1123818
`
`FEI Number
`
`1000305478
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`Y
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`1501 Graves Mill Rd
`
`Lynchburg, VA 24502 US
`
`Establishment Type
`
`Repack or Relabel Medical Device
`Manufacture Medical Device
`
`Registration Number
`
`1281950
`
`FEI Number
`
`1281950
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`N
`
`Registration Expiration 2020-04-25
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`1/37
`
`Eye Therapies Exhibit 2098, 1 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Registration Address
`
`100 RESEARCH DRIVE
`
`WILMINGTON, MA 01887 US
`
`Establishment Type
`
`Develop Specifications But Do Not Manufacture At This Facility
`Manufacture Medical Device
`
`Registration Number
`
`1032500
`
`FEI Number
`
`1032500
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`N
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`8507 PELHAM RD.
`
`GREENVILLE, SC 29615 US
`
`Establishment Type
`
`Manufacture Medical Device
`
`Registration Number
`
`1932180
`
`FEI Number
`
`1000119305
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`Y
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`499 SOVEREIGN CT.
`
`Manchester, MO 63011 US
`
`Establishment Type
`
`Manufacture Medical Device
`Repack or Relabel Medical Device
`Develop Specifications But Do Not Manufacture At This Facility
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`2/37
`
`Eye Therapies Exhibit 2098, 2 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Registration Number
`
`1313525
`
`FEI Number
`
`1317628
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`N
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`1400 North Goodman Street
`Rochester, NY 14609 US
`
`Establishment Type
`
`Complaint File Establishment per 21 CFR 820.198
`Develop Specifications But Do Not Manufacture At This Facility
`
`Registration Number
`
`1920664
`
`FEI Number
`
`1920664
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`Y
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`3365 TREE CT. INDUSTRIAL BLVD.
`Saint Louis, MO 63122 US
`
`Establishment Type
`
`Manufacture Medical Device
`Develop Specifications But Do Not Manufacture At This Facility
`Repack or Relabel Medical Device
`Remanufacture Medical Device
`
`Registration Number
`
`1119279
`
`FEI Number
`
`1119279
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`3/37
`
`Eye Therapies Exhibit 2098, 3 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`Eye Therapies Exhibit 2098, 4 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Alrex (https://fda.report/DailyMed/21c76da0-
`50a1-41c0-91b8-8cc4dcc27f60)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Methazolamide
`(https://fda.report/DailyMed/0c0ba5c7-c53e-
`4e29-a7ff-48fddc5a9258)
`Bausch & Lomb Incorporated, Micro Labs
`Limited
`
`Timolol Maleate
`(https://fda.report/DailyMed/581f80f7-4419-49e2-
`867d-40443c75409f)
`Bausch & Lomb Americas Inc., Bausch & Lomb
`Incorporated, Carton Services, Incorporated
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Muro 128 (https://fda.report/DailyMed/454f337e-
`d897-46de-ab05-1c543a33061c)
`Bausch & Lomb Incorporated
`
`Otc Medication
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Eye Itch Releif
`(https://fda.report/DailyMed/6a7be1e9-27ff-44d8-
`85ed-fc1b0017180e)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated
`
`Tetracaine Hydrochloride
`(https://fda.report/DailyMed/807dae5d-f34a-4f3d-
`9f54-dd350b056a92)
`Oceanside Pharmaceuticals, Bausch & Lomb
`Incorporated
`
`Otc Medication
`
`Otc Medication
`
`Prescription Medication
`
`GUDID 00757770571758
`(https://fda.report/GUDID/00757770571758)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb
`
`GUDID 00310119039984
`(https://fda.report/GUDID/00310119039984)
`Bausch & Lomb Incorporated
`
`GUDID 00310119039977
`(https://fda.report/GUDID/00310119039977)
`Bausch & Lomb Incorporated
`
`GUDID 00310119039960
`(https://fda.report/GUDID/00310119039960)
`Bausch & Lomb Incorporated
`
`GUDID 00310119039946
`(https://fda.report/GUDID/00310119039946)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb FCP-4373
`
`Bausch + Lomb FCP-4373
`
`Bausch + Lomb FCP-4373
`
`Bausch + Lomb FCP-4373
`
`GUDID 00757770473946
`(https://fda.report/GUDID/00757770473946)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb
`
`2022-
`05-26
`
`2022-
`05-25
`
`2022-
`05-21
`
`2022-
`05-05
`
`2022-
`04-29
`
`2022-
`04-28
`
`2022-
`04-01
`
`2022-
`03-09
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-07
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`5/37
`
`Eye Therapies Exhibit 2098, 5 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Zylet (https://fda.report/DailyMed/3dd9b060-
`5355-404d-bdf1-09ee8b52a9f5)
`Bausch & Lomb Incorporated, Bausch & Lomb
`Incoporated
`
`Bausch Lomb Inc FDA Filings
`
`Prescription Medication
`
`Timoptic (https://fda.report/DailyMed/45ac65b3-
`19f7-4f33-aebf-cadd3daa4bf1)
`Bausch & Lomb Incorporated
`
`GUDID 00757770059881
`(https://fda.report/GUDID/00757770059881)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Bausch + Lomb IVC-21
`
`PMA P910056S049
`(https://fda.report/PMA/P910056S049)
`Bausch & Lomb, Inc.
`
`enVista® Hydrophobic Acrylic
`Intraocular Lens (IOL)
`
`PMA P060022S029
`(https://fda.report/PMA/P060022S029)
`Bausch & Lomb, Inc.
`
`Akreos® Posterior Chamber
`Intraocular Lens (IOL)
`
`PMA P030002S040
`(https://fda.report/PMA/P030002S040)
`Bausch & Lomb, Inc.
`
`Crystalens Accommodating Posterior
`Chamber & Trulign Toric Intraocular
`Lenses (IOL)
`
`PMA P980006S033
`(https://fda.report/PMA/P980006S033)
`Bausch & Lomb, Inc.
`
`Bausch+ Lomb Pure Vision®
`(balafilcon A) Visibility Tinted Soft
`Contact Lenses
`
`PMA P170035S015
`(https://fda.report/PMA/P170035S015)
`Bausch And Lomb, Inc.
`
`Bausch+ Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophillic)
`Contact Lenses
`
`NDC 24208-040 (https://fda.report/NDC/24208-
`040)
`
`Xipere
`
`Bausch & Lomb Incorporated
`
`Muro 128 (https://fda.report/DailyMed/454f337e-
`d897-46de-ab05-1c543a33061c)
`Bausch & Lomb Incorporated
`
`Otc Medication
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`PMN K211786 (https://fda.report/PMN/K211786)
`Bausch + Lomb, Incorporated
`
`Independent Corneal Viewing
`Chamber (IVC-21)
`
`Timoptic (https://fda.report/DailyMed/45ac65b3-
`19f7-4f33-aebf-cadd3daa4bf1)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/806ad1b6-0de7-
`4e9a-be86-475c0ef2c340)
`Target Corporation, Bausch & Lomb Incorporated
`
`Sodium Chloride Hypertonicity Ophthalmic
`(https://fda.report/DailyMed/7546770d-bc12-
`44b8-9fe0-fc3f5e1d12d1)
`Rugby Laboratories, Bausch & Lomb
`Incorporated
`
`Prescription Medication
`
`Otc Medication
`
`Otc Medication
`
`2022-
`03-01
`
`2022-
`02-23
`
`2022-
`02-14
`
`2022-
`01-19
`
`2022-
`01-19
`
`2022-
`01-19
`
`2022-
`01-13
`
`2022-
`01-13
`
`2021-
`12-17
`
`2021-
`12-17
`
`2021-
`12-09
`
`2021-
`12-03
`
`2021-
`12-01
`
`2021-11-
`23
`
`2021-11-
`23
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`6/37
`
`Eye Therapies Exhibit 2098, 6 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Artificial Tears Lubricant Eye Drops
`(https://fda.report/DailyMed/28297fee-8185-
`4869-8f39-5bfbf8bf8bfd)
`CVS Pharmacy, Bausch & Lomb Incorporate,
`Bausch & Lomb Incorporated
`
`Zylet (https://fda.report/DailyMed/3dd9b060-
`5355-404d-bdf1-09ee8b52a9f5)
`Bausch & Lomb Incorporated, Bausch & Lomb
`Incoporated
`
`Flunisolide
`(https://fda.report/DailyMed/7c72c954-3758-
`40c3-9977-d03b25d71e0a)
`Bausch & Lomb Incorporated, Bausch Health
`Companies Inc.
`
`GUDID 00757770520022
`(https://fda.report/GUDID/00757770520022)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb EZ-28V
`
`GUDID 00757770505326
`(https://fda.report/GUDID/00757770505326)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb
`
`PMA P910056S048
`(https://fda.report/PMA/P910056S048)
`Bausch & Lomb, Inc.
`
`enVista® hydrophobic acrylic
`intraocular lens (IOL)
`
`Eye Wash (https://fda.report/DailyMed/1e742f99-
`0b29-4877-80f3-0bbe1a3207f1)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated
`
`Otc Medication
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/6043040e-3206-
`40dd-aa87-940b1a84a496)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated, Loba Feinchemie AG
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`Otc Medication
`
`Prescription Medication
`
`PMA P980006S032
`(https://fda.report/PMA/P980006S032)
`Bausch & Lomb, Inc.
`
`PureVision (balafilcon A) Contact
`Lens
`
`PMA P810025S043
`(https://fda.report/PMA/P810025S043)
`Bausch & Lomb, Inc.
`
`Amvisc Ophthalmic Viscosurgical ,
`Amvisc Plus Ophthalmic
`Viscosurgical (OVD)
`
`PMA P170035S013
`(https://fda.report/PMA/P170035S013)
`Bausch And Lomb, Inc.
`
`Rugby Eye Wash
`(https://fda.report/DailyMed/1fee974b-4c29-
`4965-bd3d-da5e219eb13a)
`Rugby Laboratories, KC Pharmaceuticals, Inc.,
`Bausch & Lomb Incorporated, KC
`Pharmaceuticals
`
`Ultra (samfilcon A) Contact Lens
`
`Otc Medication
`
`2021-11-
`23
`
`2021-11-
`09
`
`2021-11-
`03
`
`2021-
`10-29
`
`2021-
`10-29
`
`2021-
`10-14
`
`2021-
`10-05
`
`2021-
`10-01
`
`2021-
`09-15
`
`2021-
`08-27
`
`2021-
`08-27
`
`2021-
`08-27
`
`2021-
`07-31
`
`PMA P910056S046
`(https://fda.report/PMA/P910056S046)
`Bausch & Lomb, Inc.
`
`enVista Hydrophobic Acrylic
`Intraocular Lens (IOL)
`
`2021-
`07-21
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`7/37
`
`Eye Therapies Exhibit 2098, 7 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Prescription Medication
`
`Erythromycin
`(https://fda.report/DailyMed/061ddd20-94a6-
`4e3c-ba84-1ebd8529eea6)
`Bausch & Lomb Incorporated, Bausch & Lomb,
`Inc.
`
`Prescription Medication
`
`2021-
`07-17
`
`2021-
`07-13
`
`Istalol (https://fda.report/DailyMed/258bbc8d-
`00ee-45b0-ac35-6f16c4e8d45f)
`Bausch & Lomb Incorporated
`
`PMA P810025S042
`(https://fda.report/PMA/P810025S042)
`Bausch & Lomb, Inc.
`
`GUDID 10757770144096
`(https://fda.report/GUDID/10757770144096)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144089
`(https://fda.report/GUDID/10757770144089)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144072
`(https://fda.report/GUDID/10757770144072)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144065
`(https://fda.report/GUDID/10757770144065)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144058
`(https://fda.report/GUDID/10757770144058)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144041
`(https://fda.report/GUDID/10757770144041)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144034
`(https://fda.report/GUDID/10757770144034)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144027
`(https://fda.report/GUDID/10757770144027)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144010
`(https://fda.report/GUDID/10757770144010)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144003
`(https://fda.report/GUDID/10757770144003)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143990
`(https://fda.report/GUDID/10757770143990)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143983
`(https://fda.report/GUDID/10757770143983)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143976
`(https://fda.report/GUDID/10757770143976)
`Bausch & Lomb Incorporated
`
`Amvisc and Amvisc Plus Ophthalmic
`Viscosurgical (OVD)
`
`2021-
`07-08
`
`EZE-fit PMMA IOL EZE-60 8A215
`
`EZE-fit PMMA IOL EZE-60 8A210
`
`EZE-fit PMMA IOL EZE-60 8A205
`
`EZE-fit PMMA IOL EZE-60 8A200
`
`EZE-fit PMMA IOL EZE-60 8A195
`
`EZE-fit PMMA IOL EZE-60 8A190
`
`EZE-fit PMMA IOL EZE-60 8A185
`
`EZE-fit PMMA IOL EZE-60 8A180
`
`EZE-fit PMMA IOL EZE-60 8A175
`
`EZE-fit PMMA IOL EZE-60 8A170
`
`EZE-fit PMMA IOL EZE-60 8A165
`
`EZE-fit PMMA IOL EZE-60 8A160
`
`EZE-fit PMMA IOL EZE-60 8A155
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`8/37
`
`Eye Therapies Exhibit 2098, 8 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770143969
`(https://fda.report/GUDID/10757770143969)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143952
`(https://fda.report/GUDID/10757770143952)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143945
`(https://fda.report/GUDID/10757770143945)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143938
`(https://fda.report/GUDID/10757770143938)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143921
`(https://fda.report/GUDID/10757770143921)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143914
`(https://fda.report/GUDID/10757770143914)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143907
`(https://fda.report/GUDID/10757770143907)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143891
`(https://fda.report/GUDID/10757770143891)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143884
`(https://fda.report/GUDID/10757770143884)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143877
`(https://fda.report/GUDID/10757770143877)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143860
`(https://fda.report/GUDID/10757770143860)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097644
`(https://fda.report/GUDID/10757770097644)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097620
`(https://fda.report/GUDID/10757770097620)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097606
`(https://fda.report/GUDID/10757770097606)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097583
`(https://fda.report/GUDID/10757770097583)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097569
`(https://fda.report/GUDID/10757770097569)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097545
`(https://fda.report/GUDID/10757770097545)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL EZE-60 8A150
`
`EZE-fit PMMA IOL EZE-60 8A145
`
`EZE-fit PMMA IOL EZE-60 8A140
`
`EZE-fit PMMA IOL EZE-60 8A135
`
`EZE-fit PMMA IOL EZE-60 8A130
`
`EZE-fit PMMA IOL EZE-60 8A125
`
`EZE-fit PMMA IOL EZE-60 8A120
`
`EZE-fit PMMA IOL EZE-60 8A115
`
`EZE-fit PMMA IOL EZE-60 8A110
`
`EZE-fit PMMA IOL EZE-60 8A105
`
`EZE-fit PMMA IOL EZE-60 8A100
`
`EZE-fit PMMA IOL P359UV 2R450
`
`EZE-fit PMMA IOL P359UV 2R440
`
`EZE-fit PMMA IOL P359UV 2R430
`
`EZE-fit PMMA IOL P359UV 2R420
`
`EZE-fit PMMA IOL P359UV 2R410
`
`EZE-fit PMMA IOL P359UV 2R400
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`9/37
`
`Eye Therapies Exhibit 2098, 9 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770097521
`(https://fda.report/GUDID/10757770097521)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097507
`(https://fda.report/GUDID/10757770097507)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097484
`(https://fda.report/GUDID/10757770097484)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097460
`(https://fda.report/GUDID/10757770097460)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097446
`(https://fda.report/GUDID/10757770097446)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097422
`(https://fda.report/GUDID/10757770097422)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097408
`(https://fda.report/GUDID/10757770097408)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097385
`(https://fda.report/GUDID/10757770097385)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097361
`(https://fda.report/GUDID/10757770097361)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097347
`(https://fda.report/GUDID/10757770097347)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097330
`(https://fda.report/GUDID/10757770097330)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097323
`(https://fda.report/GUDID/10757770097323)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097316
`(https://fda.report/GUDID/10757770097316)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097309
`(https://fda.report/GUDID/10757770097309)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097293
`(https://fda.report/GUDID/10757770097293)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097286
`(https://fda.report/GUDID/10757770097286)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097279
`(https://fda.report/GUDID/10757770097279)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL P359UV 2R390
`
`EZE-fit PMMA IOL P359UV 2R380
`
`EZE-fit PMMA IOL P359UV 2R370
`
`EZE-fit PMMA IOL P359UV 2R360
`
`EZE-fit PMMA IOL P359UV 2R350
`
`EZE-fit PMMA IOL P359UV 2R340
`
`EZE-fit PMMA IOL P359UV 2R330
`
`EZE-fit PMMA IOL P359UV 2R320
`
`EZE-fit PMMA IOL P359UV 2R310
`
`EZE-fit PMMA IOL P359UV 2R300
`
`EZE-fit PMMA IOL P359UV 2R295
`
`EZE-fit PMMA IOL P359UV 2R290
`
`EZE-fit PMMA IOL P359UV 2R285
`
`EZE-fit PMMA IOL P359UV 2R280
`
`EZE-fit PMMA IOL P359UV 2R275
`
`EZE-fit PMMA IOL P359UV 2R270
`
`EZE-fit PMMA IOL P359UV 2R265
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`10/37
`
`Eye Therapies Exhibit 2098, 10 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770097262
`(https://fda.report/GUDID/10757770097262)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097255
`(https://fda.report/GUDID/10757770097255)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097248
`(https://fda.report/GUDID/10757770097248)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097231
`(https://fda.report/GUDID/10757770097231)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097224
`(https://fda.report/GUDID/10757770097224)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097217
`(https://fda.report/GUDID/10757770097217)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097200
`(https://fda.report/GUDID/10757770097200)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097194
`(https://fda.report/GUDID/10757770097194)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097187
`(https://fda.report/GUDID/10757770097187)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097170
`(https://fda.report/GUDID/10757770097170)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097163
`(https://fda.report/GUDID/10757770097163)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097156
`(https://fda.report/GUDID/10757770097156)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097149
`(https://fda.report/GUDID/10757770097149)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097132
`(https://fda.report/GUDID/10757770097132)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097125
`(https://fda.report/GUDID/10757770097125)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097118
`(https://fda.report/GUDID/10757770097118)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097101
`(https://fda.report/GUDID/10757770097101)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL P359UV 2R260
`
`EZE-fit PMMA IOL P359UV 2R255
`
`EZE-fit PMMA IOL P359UV 2R250
`
`EZE-fit PMMA IOL P359UV 2R245
`
`EZE-fit PMMA IOL P359UV 2R240
`
`EZE-fit PMMA IOL P359UV 2R235
`
`EZE-fit PMMA IOL P359UV 2R230
`
`EZE-fit PMMA IOL P359UV 2R225
`
`EZE-fit PMMA IOL P359UV 2R220
`
`EZE-fit PMMA IOL P359UV 2R215
`
`EZE-fit PMMA IOL P359UV 2R210
`
`EZE-fit PMMA IOL P359UV 2R205
`
`EZE-fit PMMA IOL P359UV 2R200
`
`EZE-fit PMMA IOL P359UV 2R195
`
`EZE-fit PMMA IOL P359UV 2R190
`
`EZE-fit PMMA IOL P359UV 2R185
`
`EZE-fit PMMA IOL P359UV 2R180
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`11/37
`
`Eye Therapies Exhibit 2098, 11 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770097095
`(https://fda.report/GUDID/10757770097095)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097088
`(https://fda.report/GUDID/10757770097088)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097071
`(https://fda.report/GUDID/10757770097071)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097064
`(https://fda.report/GUDID/10757770097064)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097057
`(https://fda.report/GUDID/10757770097057)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097040
`(https://fda.report/GUDID/10757770097040)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097033
`(https://fda.report/GUDID/10757770097033)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097026
`(https://fda.report/GUDID/10757770097026)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097019
`(https://fda.report/GUDID/10757770097019)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097002
`(https://fda.report/GUDID/10757770097002)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096999
`(https://fda.report/GUDID/10757770096999)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096982
`(https://fda.report/GUDID/10757770096982)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096975
`(https://fda.report/GUDID/10757770096975)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096968
`(https://fda.report/GUDID/10757770096968)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096951
`(https://fda.report/GUDID/10757770096951)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096944
`(https://fda.report/GUDID/10757770096944)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096920
`(https://fda.report/GUDID/10757770096920)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL P359UV 2R175
`
`EZE-fit PMMA IOL P359UV 2R170
`
`EZE-fit PMMA IOL P359UV 2R165
`
`EZE-fit PMMA IOL P359UV 2R160
`
`EZE-fit PMMA IOL P359UV 2R155
`
`EZE-fit PMMA IOL P359UV 2R150
`
`EZE-fit PMMA IOL P359UV 2R145
`
`EZE-fit PMMA IOL P359UV 2R140
`
`EZE-fit PMMA IOL P359UV 2R135
`
`EZE-fit PMMA IOL P359UV 2R130
`
`EZE-fit PMMA IOL P359UV 2R125
`
`EZE-fit PMMA IOL P359UV 2R120
`
`EZE-fit PMMA IOL P359UV 2R115
`
`EZE-fit PMMA IOL P359UV 2R110
`
`EZE-fit PMMA IOL P359UV 2R105
`
`EZE-fit PMMA IOL P359UV 2R100
`
`EZE-fit PMMA IOL P359UV 2R090
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`12/37
`
`Eye Therapies Exhibit 2098, 12 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770096906
`(https://fda.report/GUDID/10757770096906)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096883
`(https://fda.report/GUDID/10757770096883)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096869
`(https://fda.report/GUDID/10757770096869)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096845
`(https://fda.report/GUDID/10757770096845)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096821
`(https://fda.report/GUDID/10757770096821)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096807
`(https://fda.report/GUDID/10757770096807)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096784
`(https://fda.report/GUDID/10757770096784)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096760
`(https://fda.report/GUDID/10757770096760)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096746
`(https://fda.report/GUDID/10757770096746)
`Bausch & Lomb Incorporated
`
`Dorzolamide Hydrochloride and Timolol Maleate
`(https://fda.report/DailyMed/7f6ab3f6-3644-434c-
`b6cf-e4f111d18962)
`
`Bausch & Lomb Incorporated
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Ipratropium bromide
`(https://fda.report/DailyMed/1e92b86d-66e1-
`45e4-9e23-f9310c95bf82)
`Bausch & Lomb Incorporated
`
`Loteprednol Etabonate
`(https://fda.report/DailyMed/7bbdbd31-5a8f-
`4d69-aa8e-5b700895e804)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/6043040e-3206-
`40dd-aa87-940b1a84a496)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated, Loba Feinchemie AG
`
`Ipratropium Bromide
`(https://fda.report/DailyMed/3fd850a2-af0f-4291-
`af5d-52c8d6094e64)
`Bausch & Lomb Incorporated, Bausch Health
`Companies Inc.
`
`EZE-fit PMMA IOL P359UV 2R080
`
`EZE-fit PMMA IOL P359UV 2R070
`
`EZE-fit PMMA IOL P359UV 2R060
`
`EZE-fit PMMA IOL P359UV 2R050
`
`EZE-fit PMMA IOL P359UV 2R040
`
`EZE-fit PMMA IOL P359UV 2R030
`
`EZE-fit PMMA IOL P359UV 2R020
`
`EZE-fit PMMA IOL P359UV 2R010
`
`EZE-fit PMMA IOL P359UV 2R000
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-07
`
`2021-
`07-07
`
`2021-
`06-17
`
`2021-
`06-16
`
`2021-
`06-11
`
`2021-
`06-11
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`13/37
`
`Eye Therapies Exhibit 2098, 13 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`Eye Therapies Exhibit 2098, 14 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Prescription Medication
`
`Timolol Maleate
`(https://fda.report/DailyMed/0c488889-6c37-
`44a2-94e2-97f98d48d6fb)
`BAUSCH & LOMB INCORPORATED,
`Laboratoire Unither
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`EYE ALLERGY RELIEF
`(https://fda.report/DailyMed/253130b4-a23b-
`43a0-b125-0fa5bd01b2b6)
`CVS PHARMACY, Bausch & Lomb Incorporated
`
`Retisert (https://fda.report/DailyMed/1ab0f849-
`2a0d-47ce-ad05-768094da8cc9)
`Bausch & Lomb Incorporated, Bausch and Lomb
`Ireland Limited, Carton Service Inc.
`
`Loteprednol Etabonate
`(https://fda.report/DailyMed/7bbdbd31-5a8f-
`4d69-aa8e-5b700895e804)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`PMA P860047S034
`(https://fda.report/PMA/P860047S034)
`Bausch & Lomb, Inc.
`
`OcuCoat OVD
`
`Prescription Medication
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`PMA P910056S044
`(https://fda.report/PMA/P910056S044)
`Bausch & Lomb, Inc.
`
`2021-
`03-18
`
`2021-
`03-11
`
`2021-
`03-05
`
`2021-
`03-05
`
`2021-
`02-18
`
`2021-
`01-13
`
`2021-
`01-06
`
`enVista One-Piece Foldable Acrylic
`Intraocular Lens
`
`2020-
`12-21
`
`PMA P060022S028
`(https://fda.report/PMA/P060022S028)
`Bausch & Lomb, Inc.
`
`Akreos One-Piece Foldable Acrylic
`Intraocular Lens
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Otc Medication
`
`Eye Itch Relief
`(https://fda.report/DailyMed/7d0146a9-5073-
`4e24-954f-75b84affadc2)
`CVS Pharmacy, Bausch & Lomb Incorporated
`
`Otc Medication
`
`Cromolyn Sodium
`(https://fda.report/DailyMed/379f4b59-6866-
`4b5c-9b1b-d8a35b741461)
`Bausch & Lomb Incorporated, Cambrex
`Profarmaco Milano Srl, Aventis Pharma
`Manufacturing Pte LTD.
`
`Otc Medication
`
`Eye Wash
`(https://fda.report/DailyMed/354402ad-581d-
`47e7-9fd3-933bef281ff4)
`Kroger Company, Bausch & Lomb Incorporated
`
`Otc Medication
`
`2020-
`12-21
`
`2020-
`12-18
`
`2020-
`12-16
`
`2020-
`12-10
`
`2020-
`12-09
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`15/37
`
`Eye Therapies Exhibit 2098, 15 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Tobramycin and Dexamethasone
`(https://fda.report/DailyMed/33de419e-a89b-
`47e5-952b-87e837f5d531)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/806ad1b6-0de7-
`4e9a-be86-475c0ef2c340)
`Target Corporation, Bausch & Lomb Incorporated
`
`Dorzolamide Hydrochloride and Timolol Maleate
`(https://fda.report/DailyMed/7f6ab3f6-3644-434c-
`b6cf-e4f111d18962)
`
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`PMA P170035S011
`(https://fda.report/PMA/P170035S011)
`Bausch And Lomb, Inc.
`
`Bausch + Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophilic)
`Contact Lenses
`
`Sodium Chloride Hypertonicity Ophthalmic
`(https://fda.report/DailyMed/7546770d-bc12-
`44b8-9fe0-fc3f5e1d12d1)
`Rugby Laboratories, Bausch & Lomb
`Incorporated
`
`Otc Medication
`
`Eye Wash
`(https://fda.report/DailyMed/354402ad-581d-
`47e7-9fd3-933bef281ff4)
`Kroger Company, Bausch & Lomb Incorporated
`
`Otc Medication
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Otc Medication
`
`PMA P170035S010
`(https://fda.report/PMA/P170035S010)
`Bausch And Lomb, Inc.
`
`Bausch + Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophilic)
`Contact Lenses
`
`Macugen (https://fda.report/DailyMed/45d03177-
`5d52-492c-b2e0-01afc7c8d2e0)
`Bausch & Lomb Incorporated, Pfizer
`Manufacturing Belgium NV
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Prescription Medication
`
`NDC 24208-023 (https://fda.report/NDC/24208-
`023)
`
`Bausch & Lomb Incorporated
`
`Methazolamide
`
`NDC 24208-022 (https://fda.report/NDC/24208-
`022)
`
`Bausch & Lomb Incorporated
`
`Methazolamide
`
`2020-
`12-09
`
`2020-
`12-08
`
`2020-
`12-05
`
`2020-11-
`19
`
`2020-11-
`19
`
`2020-11-
`07
`
`2020-
`10-29
`
`2020-
`10-19
`
`2020-
`10-15
`
`2020-
`10-10
`
`2020-
`10-02
`
`2020-
`10-02
`
`PMA P810025S040
`(https://fda.report/PMA/P810025S040)
`Bausch & Lomb, Inc.
`
`Amvisc and Amvisc Plus Ophthalmic
`Viscosurgical (OVD)
`
`2020-
`10-01
`
`PMA P980006S030
`(https://fda.report/PMA/P980006S030)
`Bausch & Lomb, Inc.
`
`Bausch + Lomb PureVision
`(balafilcon A) Visibility Tinted Soft
`(hydrophilic) Contact Lenses
`
`PMA P170035S009
`(https://fda.report/PMA/P170035S009)
`Bausch And Lomb, Inc.
`
`Bausch + Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophilic)
`Contact Lenses
`
`2020-
`09-28
`
`2020-
`09-28
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`16/37
`
`Eye Therapies Exhibit 2098, 16 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`PMN K200416 (https://fda.report/PMN/K200416)
`Bausch & Lomb Incorporated
`
`Boston One Step Liquid Enzymatic
`Cleaner
`
`Sodium Chlorode Hypertonicity Ophthalmic
`Solution (https://fda.report/DailyMed/822d25c0-
`71b3-421d-b702-4cded0c4ca32)
`Rugby Laboratories, Bausch & Lomb
`Incorporated
`
`Dorzolamide HCl
`(https://fda.report/DailyMed/8417d162-65a1-
`4266-bca7-707af1193bf3)
`Bausch & Lomb Incorporated
`
`Dexamethasone Sodium Phosphate
`(https://fda.report/DailyMed/6bdcefbe-51e3-
`4ca4-afda-5aeca7b6fa73)
`Bausch & Lomb Incorporated
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Zylet (https://fda.report/DailyMed/3dd9b060-
`5355-404d-bdf1-09ee8b52a9f5)
`Bausch & Lomb Incorporated, Bausch & Lomb
`Incoporated
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Tobramycin and Dexamethasone
`(https://fda.report/DailyMed/33de419e-a89b-
`47e5-952b-87e837f5d531)
`Bausch & Lomb Incorporated
`
`Dorzolamide HCl
`(https://fda.report/DailyMed/8417d162-65a1-
`4266-bca7-707af1193bf3)
`Bausch & Lomb Incorporated
`
`Dorzolamide HCl
`(https://fda.report/DailyMed/8417d162-65a1-
`4266-bca7-707af1193bf3)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/873a072f-159b-
`44b8-aad8-33963d961afb)
`Wal-Mart Stores Inc, Bausch & Lomb
`Incorporated, Loba Feinchemie AG
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Prescrip